AI assistant
GlaxoSmithKline PLC — Director's Dealing 2017
Feb 14, 2017
5262_rns_2017-02-14_7b9f8903-5541-40e9-8e91-cffd9aefab2b.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8612W
GlaxoSmithKline PLC
14 February 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Sir Andrew Witty
b)
Position/status
Chief Executive Officer
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Disposal of 63,441 Ordinary Shares on 10 February 2017 at nil consideration, by way of a gift to the University of Nottingham to help develop student skills and employability. The closing price of an Ordinary Share on 10 February 2017 was £15.91.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £0.00 | 63,441 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2017-02-10
f)
Place of the transaction
n/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLZLFFDLFZBBF